Nextgen Healthcare Stock Earnings Per Share
| NXGNDelisted Stock | USD 16.53 0.05 0.30% |
Nextgen Healthcare fundamentals help investors to digest information that contributes to Nextgen Healthcare's financial success or failures. It also enables traders to predict the movement of Nextgen Stock. The fundamental analysis module provides a way to measure Nextgen Healthcare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nextgen Healthcare stock.
Nextgen |
Nextgen Healthcare Company Earnings Per Share Analysis
Nextgen Healthcare's Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Nextgen Healthcare Earnings Per Share | (0.09) X |
Most of Nextgen Healthcare's fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nextgen Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
CompetitionAccording to the company disclosure, Nextgen Healthcare has an Earnings Per Share of -0.09 times. This is 101.08% lower than that of the Health Care Technology sector and significantly lower than that of the Health Care industry. The earnings per share for all United States stocks is 102.88% higher than that of the company.
Nextgen Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nextgen Healthcare's direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Nextgen Healthcare could also be used in its relative valuation, which is a method of valuing Nextgen Healthcare by comparing valuation metrics of similar companies.Nextgen Healthcare is currently under evaluation in earnings per share category among its peers.
Nextgen Fundamentals
| Return On Equity | -0.0144 | |||
| Return On Asset | 0.038 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 1.68 B | |||
| Shares Outstanding | 67.1 M | |||
| Shares Owned By Insiders | 33.55 % | |||
| Shares Owned By Institutions | 81.43 % | |||
| Number Of Shares Shorted | 4.84 M | |||
| Price To Earning | 253.66 X | |||
| Price To Book | 2.93 X | |||
| Price To Sales | 2.10 X | |||
| Revenue | 653.17 M | |||
| Gross Profit | 332.83 M | |||
| EBITDA | 52.93 M | |||
| Net Income | (2.65 M) | |||
| Cash And Equivalents | 70.73 M | |||
| Cash Per Share | 1.05 X | |||
| Total Debt | 274.76 M | |||
| Debt To Equity | 0.03 % | |||
| Current Ratio | 1.29 X | |||
| Book Value Per Share | 6.31 X | |||
| Cash Flow From Operations | 43.66 M | |||
| Short Ratio | 6.60 X | |||
| Earnings Per Share | (0.09) X | |||
| Price To Earnings To Growth | 2.56 X | |||
| Target Price | 23.96 | |||
| Number Of Employees | 2.78 K | |||
| Beta | 0.77 | |||
| Market Capitalization | 1.61 B | |||
| Total Asset | 896.1 M | |||
| Retained Earnings | 127.6 M | |||
| Working Capital | 203.71 M | |||
| Current Asset | 101.06 M | |||
| Current Liabilities | 46.08 M | |||
| Z Score | 4.9 | |||
| Annual Yield | 0.05 % | |||
| Net Asset | 896.1 M |
About Nextgen Healthcare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nextgen Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nextgen Healthcare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nextgen Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Nextgen Healthcare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nextgen Healthcare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nextgen Healthcare will appreciate offsetting losses from the drop in the long position's value.Moving against Nextgen Stock
| 0.62 | SSNLF | Samsung Electronics | PairCorr |
| 0.6 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.57 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
| 0.53 | DD | Dupont De Nemours Fiscal Year End 4th of February 2025 | PairCorr |
| 0.45 | XOM | Exxon Mobil Corp Fiscal Year End 7th of February 2025 | PairCorr |
The ability to find closely correlated positions to Nextgen Healthcare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nextgen Healthcare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nextgen Healthcare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nextgen Healthcare to buy it.
The correlation of Nextgen Healthcare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nextgen Healthcare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nextgen Healthcare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nextgen Healthcare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Consideration for investing in Nextgen Stock
If you are still planning to invest in Nextgen Healthcare check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nextgen Healthcare's history and understand the potential risks before investing.
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |